Researchers Karen Wernli and Erika Kiniry share insights on an exceptional 2024-2025 flu season.
Interim data for the 2023-2024 flu season shows that the vaccine has protected all age groups.
KPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases
KPWHRI infectious disease expert Dr. Michael Jackson reports on the latest influenza news and how we’re learning to improve future predictions.
